STING program (AnaMar Medical)

N/A

Report date: 2025/03/20 15:09:22
NME

Base Information

Drug NameSTING program (AnaMar Medical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonists
TargetsSerotonin 2b (5-HT2b) receptor
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMar-Med
China Registration ClassN/A

Develop Information

Active CompaniesMar-Med
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A